Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Integrated Pharmaceuticals Inc INTP

Healthcare Drug Manufacturers - Specialty & Generic Diagnostics & Research
Integrated Pharmaceuticals, Inc. is a development-stage company. As of June 30, 2008, the Company is engaged in the development of clinically active pharmaceutical compounds, including active small molecules and recombinant deoxyribonucleic acid (DNA) technology derived products.

Recent & Breaking News (GREY:INTP)

Intec Pharma Announces Pricing of $50.0 Million Public Offering of Ordinary Shares

PR Newswire August 16, 2017

Intec Pharma Granted Patent in Hong Kong for Accordion Pill™ Carbidopa / Levodopa

PR Newswire July 19, 2017

Intec Pharma Appoints U.S. Life Sciences Executive and Vice Chairman Jeffrey A. Meckler as Chief Executive Officer

PR Newswire July 10, 2017

Intec Pharma Granted U.S. Patent for Accordion Pill™ Comprising Levodopa for Improved Treatment of Parkinson's Diseases Symptoms

PR Newswire May 24, 2017

Intec Pharma Enters into Agreement with the Michael J. Fox Foundation Around Its Phase III Trial Recruitment

PR Newswire November 28, 2016

Intec Pharma to Sponsor Investigator Meeting for Pivotal Phase III Study of Accordion Pill Carbidopa/Levodopa in Advanced Parkinson's Disease Patients

PR Newswire November 9, 2016

Intec Pharma Announces Protocol Amendment to Phase III Study of Accordion Pill Carbidopa/Levodopa in Advanced Parkinson's Disease Patients

PR Newswire November 7, 2016

Intec Pharma Granted Chinese Patent for Accordion PillTM Carbidopa / Levodopa

Business Wire October 31, 2016

Intec Pharma Announces Planned Management Changes

PR Newswire June 3, 2016

Intec Pharma Receives Approval for US$5.2 Million Grant

PR Newswire May 31, 2016

Intec Pharma to Nominate Dr. John W. Kozarich as Chairman of the Board of Directors

PR Newswire May 16, 2016

Intec Pharma Appoints VP of Clinical and Regulatory Affairs

PR Newswire May 3, 2016

Intec Pharma Expands Intellectual Property for AP-CDLD with Patent in South Korea

PR Newswire April 6, 2016

Intec Pharma Enrolls First Patient in Pivotal Phase III Clinical Trial of AP-CDLD for Advanced Parkinson's Disease Patients

PR Newswire April 4, 2016

Mr. Zvika Joseph to Step Down as Chairman of the Board of Directors

Marketwired March 17, 2016

Intec Pharma Reports 2015 Fourth Quarter and Full-Year Financial Results

Marketwired March 14, 2016

Intec Pharma Ltd. Announces Availability of Its Annual Report on Form 20-F Through Its Website

Marketwired March 14, 2016

Intec Pharma Ltd.: Notice of Special General Meeting of Shareholders

Marketwired March 14, 2016

Intec Pharma Completed a Phase I Clinical Trial With Its Third Pipeline Product

Marketwired March 10, 2016

Intec Pharma to Present at Biotech Showcase 2016

Marketwired January 5, 2016